These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 981026)

  • 1. Effect of processing technique of different dosage forms on dissolution rate of caffeine and salicylamide.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1976; 28(4):361-7. PubMed ID: 981026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution rates of caffeine and salicylamide from tablets.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1974; 26(5):549-53. PubMed ID: 4427817
    [No Abstract]   [Full Text] [Related]  

  • 3. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of solid dispersion technique in the preparation of therapeutic tablets. Part 1: Paracetamol, amylobarbitone, and caffeine tablets.
    El-Banna HM; Eshra AG; Hammouda Y
    Pharmazie; 1977; 32(8-9):511-5. PubMed ID: 145597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dissolution mechanism in a system undergoing complexation: salicylamide in caffeine solution.
    Donbrow M; Touitou E
    J Pharm Pharmacol; 1977 Sep; 29(9):524-8. PubMed ID: 21254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the granulation process on nitrofurantoin granule characteristics.
    Arnaud P; Brossard D; Chaumeil JC
    Drug Dev Ind Pharm; 1998 Jan; 24(1):57-66. PubMed ID: 15605598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct spectrophotometric determination of salicylic acid, acetylsalicylic acid, salicylamide, caffeine, and phenacetin in tablets or powders.
    Clayton AW; Thiers RE
    J Pharm Sci; 1966 Apr; 55(4):404-7. PubMed ID: 5960293
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release dosage form of phenylpropanolamine hydrochloride (3). Application of factorial design.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(4):439-44. PubMed ID: 7931943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of incorporation technics of water soluble macromolecular binders on the properties of fluidized-bed dried granules].
    Richter M; Rahn HW; Voigt R
    Pharmazie; 1989 Jan; 44(1):43-6. PubMed ID: 2727029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of different formulations of atenolol.
    Yasmeen R; Shoaib MH; Khalid H
    Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some factors affecting properties and dissolution behavior of tableted furosemide microspheres.
    Akbuğa J
    Pharmazie; 1992 Feb; 47(2):128-31. PubMed ID: 1635921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.
    Mäki R; Suihko E; Rost S; Heiskanen M; Murtomaa M; Lehto VP; Ketolainen J
    J Pharm Sci; 2007 Feb; 96(2):438-47. PubMed ID: 17075868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
    Wu Y; Ghaly ES
    P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.